1-819-824-6869 info@spharm-inc.com Français
  • Home
  • About Us
  • Services
    • Drug Regulatory Services in Canada
    • Electronic Common Technical Document – eCTD
    • Product Development
    • Pharmacovigilance
    • Compliance and quality
    • Services through partners
    • Regulatory Training & Consulting
  • Knowledge Center
    • Covid-19 Clinical Trials Worldwide Reports
    • AN eGUIDE – The Drug Review and Approval Process in Canada
    • AN INFOGRAPHIC – Drug Review & Approval Process in Canada
    • Canadian Drug Regulatory Glossary
    • FAQs
  • Insights/Blog
  • Contact Us
  • Home
  • About Us
  • Services
    • Drug Regulatory Services in Canada
    • Electronic Common Technical Document – eCTD
    • Product Development
    • Pharmacovigilance
    • Compliance and quality
    • Services through partners
    • Regulatory Training & Consulting
  • Knowledge Center
    • Covid-19 Clinical Trials Worldwide Reports
    • AN eGUIDE – The Drug Review and Approval Process in Canada
    • AN INFOGRAPHIC – Drug Review & Approval Process in Canada
    • Canadian Drug Regulatory Glossary
    • FAQs
  • Insights/Blog
  • Contact Us

CAPRA Symposium 2017

 CAPRA Symposium 2017
09 June 2017
CAPRA Symposium 2017, SPharm will be present!
In collaboration with the International Generic Drug Regulators Programme (IGDRP) and Health Canada, CAPRA, will host a one day symposium. It will be an ideal opportunity to hear from key international regulators and industry representatives on drivers and the progress of the IGDRP activities and on other initiatives facing regulators and the pharmaceutical industry.
The Canadian Association of Professionals in Regulatory Affairs (CAPRA) is a non-profit organization that serves the pharmaceutical, biologics, medical device, cosmetic and natural health product industries in Canada.
SPharm Canada

With over 20 years of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Après plus de 20 ans de résultats et de succès constants, SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.

Canadian Association of Professionals in Regulatory Affairs, canadian drug approval process, capra symposium, clinical trial approval canada, drug approval consultant canada, drug approval consultants canada, drug approval process in canada, drug regulatory consultant canada, drug regulatory process canada, health canada drug approval, Medical Device Canada, Medical Devices Licence Applications
CAPRA Symposium 20172017-06-092018-02-28https://spharm-inc.com/wp-content/uploads/2017/12/spharm-logo.pngSPharm - Canada's Drug Regulatory Expertshttps://spharm-inc.com/wp-content/uploads/2017/06/capra-symposium.png200px200px
SPharm Canada
SPharm Canada
With over 20 years of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada. Après plus de 20 ans de résultats et de succès constants, SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d'homologation de leurs médicaments (et autres produits de santé) au Canada.
SEARCH
CATEGORIES
  • Covid 19
  • Drug Approval Process in Canada
  • Events
  • Health Canada
eGUIDE
FAQ
KEYWORDS
health canada regulatory hiring regulatory affair professionals how are drugs reviewed in canada How Drugs are reviewed in Canada Hydroxychloroquine Janssen vaccine johnson & johnson vaccine Lopinavir Market Access Summit Medicago Vaccine Medical Device Canada Medical Devices Licence Applications Medical Instrument Canada Moderna Vaccine New Drug Submission non-eCTD electronic-only format Notice of Compliance Novavax Vaccine novel coronavirus Ontario Covid-19 Clinical Trials Pfizer Vaccine pharmaceutical conference canada Pharma Conference pharmacovigilance pharmacovigilance canada Picking the Right Drug Regulatory Affairs Professional présentation de drogue nouvelle process d'approbation des medicaments au canada Process d'evaluation des medicaments au canada processus d'approbation des médicaments au Canada Processus de réglementation des médicaments au Canada Protease Inhibitors Quebec Covid-19 Clinical Trials Regulatory Affairs Needs revue des médicaments au canada Ritonavir Sante Canada approbation Santé Canada process d'approbation SARS-CoV-2 SARS-CoV-2 vaccine sinopharm vaccine sinovac vaccine Susanne Picard The Common Technical Document wuhan virus

1.819.824.6869

info@spharm-inc.com



    [recaptcha theme:dark size:normal]

    SPharm © 2021 All rights reserved